Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy

Article Contents

Article Navigation > Journal of Kunming Medical University > 2011 > 32(06):

Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy[J]. Journal of Kunming Medical University, 2011, 32(06).

Citation:

Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy[J]. Journal of Kunming Medical University, 2011, 32(06).

Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy[J]. Journal of Kunming Medical University, 2011, 32(06).

Citation:

Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy[J]. Journal of Kunming Medical University, 2011, 32(06).

PDF( 0 KB)

Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy

Abstract

Abstract

Objective To observe cardiac events,bleeding complications and blood coagulation function after using fondaparinux in acute coronary syndromes after interventional therapy,and explore the effect in the short term and the bleeding risks of fondaparinux.Methods 103 cases with acute coronary syndromes were selected from Jan 2010 to Feb 2011 in the 1st Affiliated Hospital of Kunming Medical University and assigned to receive either fondaparinux(2.5 mg daily or control for up to 8 days)or low molecular weight he...
- Acute coronary syndromes,
- Fondaparinux,
- Low molecular weight heparin calcium,
- Percutaneous Coronary Intervention

FullText(HTML)

References(0)

References

Relative Articles(6)

Relative Articles

[1]	Bin FANG, Yunpeng HU, Na HAO. Clinical Relationship between Glycolysis，Iron Metabolism Indicators and Cardiovascular Status in Patients with Chronic Obstructive Pulmonary Disease-Coronary Artery Disease. Journal of Kunming Medical University, 2025, 46(10): 85-90. doi: 10.12259/j.issn.2095-610X.S20251010
[2]	Jizhou LI, Hongwei LI, Ye ZHANG, Hongling YANG. Research Advances in D-dimer/Fibrinogen Ratio and Fibrinogen/Albumin Ratio in Acute Coronary Syndromes. Journal of Kunming Medical University, 2025, 46(11): 1-6.
[3]	Huan LI, Zhong ZHONG. Differences of Adverse Events and Survival Rates of Patients with Premature Coronary Artery Disease after PCI in Different Age Groups. Journal of Kunming Medical University, 2022, 43(6): 99-104. doi: 10.12259/j.issn.2095-610X.S20220607
[4]	Hui DUAN, Dan HAN, Ling MA, De-yan LI, Shao-lei KANG. Evaluation of CCTA Combined with Rest Myocardial Perfusion after PCI. Journal of Kunming Medical University, 2021, 42(2): 70-74. doi: 10.12259/j.issn.2095-610X.S20210229
[5]	Bin YANG, Ni-ni TIAN, Juan MA. The Guiding Effect of FFR in Interventional Treatment of Multivessel Coronary Artery Disease and the Impact on Adverse Event. Journal of Kunming Medical University, 2021, 42(9): 90-94. doi: 10.12259/j.issn.2095-610X.S20210930
[6]	Hai-ping ZHANG, Shu-juan YANG, Li-xia YANG, Zhao-juan RUAN, Rui-wei GUO. Effect of Hyperhomocysteinemia on Cardiac Function and Mortality of Patients with Acute Myocardial Infarction Concomitant Hypertension underwent Primary Percutaneous Coronary Intervention after 6 Months. Journal of Kunming Medical University, 2021, 42(3): 73-78. doi: 10.12259/j.issn.2095-610X.S20210319